Frequency News and Research

RSS

Migraine prevention guidelines released

The latest migraine prevention guidelines will be presented at the American Academy of Neurology's annual meeting in New Orleans and published simultaneously in the journal Neurology.

24 Apr 2012

Frequent family meals can lead to decreased obesity

"Come and get it!" A phrase historically proclaiming that the communal meal is ready, is heard all too infrequently among contemporary American households, especially as children get older.

24 Apr 2012

Botox injections may improve frequency of chronic daily and migraine headaches

Although botulinum toxin A injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for patients with chronic migraine headaches and chronic daily headaches, although botox injections were not associated with greater benefit than placebo for preventing episodic migraine or chronic tension-type headaches, according to an article in the April 25 issue of JAMA.

24 Apr 2012

Study shows how MRSA epidemics may emerge and spread at molecular level

National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) epidemics in most of Asia.

23 Apr 2012

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

21 Apr 2012

U.S. Marshals seize contaminated ultrasound gel of Pharmaceutical Innovations

U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product manufactured between June 2011 and December 2011.

19 Apr 2012

Perampanel drug may significantly reduce seizure frequency

A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure frequency in people whose recurrent seizures have been resistant to even the latest medications, new Johns Hopkins-led research suggests.

19 Apr 2012

MP3 players might increase risk of distraction in drivers

Consumers are increasingly using MP3 players in their vehicles, and auto makers have responded: Data show that 90% of new vehicles sold in the United States have MP3 connectivity. Makers of aftermarket MP3 controllers are also responding with devices that have claimed to decrease driver distraction. But according to human factors/ergonomics researcher John D. Lee and colleagues, MP3 players might increase distraction risk, depending on which devices drivers use and how long they look away from the road while searching for their favorite song.

17 Apr 2012

TJUH opens new treatment center for Barrett's esophagus

Thomas Jefferson University Hospital announces the opening of its new Jefferson Barrett's Esophagus Treatment Center, one of only a few dedicated Barrett's centers in the country and the first multidisciplinary center solely dedicated to treating Barrett's esophagus disease in Philadelphia.

16 Apr 2012

Females athletes more affected by overuse injuries

Overuse injuries -found most often in low-contact sports that involve long training sessions or where the same movement is repeated numerous times - make up nearly 30 percent of all injuries sustained by collegiate athletes.

16 Apr 2012

Asthma treatment still inadequate in Australia

Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.

15 Apr 2012

Study looks at how personality traits might influence what and how people remember

We all have them - positive memories of personal events that are a delight to recall, and painful recollections that we would rather forget. A new study reveals that what we do with our emotional memories and how they affect us has a lot to do with our gender, personality and the methods we use (often without awareness) to regulate our feelings.

12 Apr 2012

Research explores power of offering colon cancer screening options

Researchers find that when given a choice of methods, more people will opt to get screened for colon cancer. Meanwhile, a separate study found that insurance coverage of lung cancer screenings for high-risk patients could prevent -- at a low cost -- thousands of deaths annually.

12 Apr 2012

People with PNES do not necessarily experience more frequent or severe stressful events

Based on their clinical experience and observations, a team of Johns Hopkins physicians and psychologists say that more than one-third of the patients admitted to The Johns Hopkins Hospital's inpatient epilepsy monitoring unit for treatment of intractable seizures have been discovered to have stress-triggered symptoms rather than a true seizure disorder.

12 Apr 2012

Two CNVs may increase risk of aggressive prostate cancer

An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer.

10 Apr 2012

AIUM announces 2012 EER grant recipients

The American Institute of Ultrasound in Medicine (AIUM) announced the recipients of its 2012 Endowment for Education and Research (EER) grants at the 2012 AIUM Annual Convention in Phoenix, Arizona.

6 Apr 2012

Sucampo announces positive results from lubiprostone phase 3 trial on OBD

Sucampo Pharmaceuticals, Inc. today announced positive top-line results from an open-label phase 3 clinical trial designed to evaluate the long-term safety and efficacy of lubiprostone in opioid-induced bowel dysfunction (OBD) patients with chronic, non-cancer-related pain.

6 Apr 2012